Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why
Sales of PBYI's sole-marketed drug, Nerlynx, exceeded management's expectations in fourth-quarter 2024. Also, ongoing studies on alisertib are progressing well.
Alligator Bioscience Announces FDA Orphan Drug Designation for HLX22/AC101 in Gastric Cancer
LUND, SE / ACCESS Newswire / March 20, 2025 /Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that the U.S. Food ...
The Pharma Letter4d
FDA grants traditional appro for Keytruda in GEJ
The US Food and Drug Administration (FDA) has granted traditional approval to Merck & Co’s (NYSE: MRK) Keytruda ...
MPR5d
FDA Grants Traditional Approval to Keytruda for HER2+ Gastric/GEJ Cancer
When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.
CURE5d
How Antibody-Drug Conjugates Have Impacted HER2-Positive Breast Cancer Treatment
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Targeted Oncology5d
FDA Grants Orphan Drug Designation to HLX22 for Gastric Cancer Treatment
The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...